Table 2.
Pathologic Complete Response Rate First 48 Evaluable Patients on Each Arm PRIMARY ENDPOINT
| Capecitabine/Irinotecan/RT (n=48) |
Capecitabine/Oxaliplatin/RT (n=48) |
|
|---|---|---|
| Number Evaluable | 48 | 48 |
| Number with Pathologic Complete Response | 5 | 10 |
| Percentage with Pathologic Complete Response | 10.4 | 20.8 |
| Exact 95% Confidence Interval for Percentage with Pathologic Complete Response | (3.5, 22.7) | (10.5, 35.0) |